Company page

Cns Pharmaceuticals, Inc.

Cns Pharmaceuticals, Inc. is a public company traded under the ticker CNSP in the American market. The company has a market capitalization of approximately $7.64 million. Cns Pharmaceuticals focuses on developing innovative therapies for the treatment of central nervous system cancers.